Zocco, Maria Assunta
 Distribuzione geografica
Continente #
EU - Europa 6.668
NA - Nord America 6.135
AS - Asia 5.307
SA - Sud America 1.093
AF - Africa 159
OC - Oceania 55
Continente sconosciuto - Info sul continente non disponibili 23
Totale 19.440
Nazione #
US - Stati Uniti d'America 5.914
DE - Germania 2.586
SG - Singapore 2.467
CN - Cina 1.497
SE - Svezia 1.112
BR - Brasile 883
IT - Italia 877
UA - Ucraina 380
FR - Francia 362
GB - Regno Unito 333
IE - Irlanda 250
VN - Vietnam 228
IN - India 223
FI - Finlandia 209
ID - Indonesia 174
RU - Federazione Russa 138
CA - Canada 126
TR - Turchia 118
PL - Polonia 92
AR - Argentina 83
HK - Hong Kong 77
KR - Corea 64
BD - Bangladesh 61
JP - Giappone 57
BE - Belgio 55
MX - Messico 55
IQ - Iraq 54
NL - Olanda 53
AU - Australia 50
SA - Arabia Saudita 47
ZA - Sudafrica 42
IR - Iran 37
AT - Austria 36
CH - Svizzera 28
EC - Ecuador 27
AE - Emirati Arabi Uniti 25
LT - Lituania 25
CZ - Repubblica Ceca 23
PK - Pakistan 23
ES - Italia 21
IL - Israele 21
PH - Filippine 21
VE - Venezuela 21
RO - Romania 19
CI - Costa d'Avorio 18
PY - Paraguay 18
CO - Colombia 17
EG - Egitto 16
EU - Europa 16
MA - Marocco 16
PE - Perù 16
CL - Cile 15
TN - Tunisia 15
KE - Kenya 14
UZ - Uzbekistan 14
JO - Giordania 12
TW - Taiwan 12
PT - Portogallo 11
MY - Malesia 10
UY - Uruguay 10
NP - Nepal 9
GR - Grecia 8
PA - Panama 8
AL - Albania 7
KG - Kirghizistan 7
TT - Trinidad e Tobago 7
AZ - Azerbaigian 6
BH - Bahrain 6
DZ - Algeria 6
SD - Sudan 6
AO - Angola 5
EE - Estonia 5
GE - Georgia 5
HN - Honduras 5
NO - Norvegia 5
TH - Thailandia 5
BG - Bulgaria 4
CR - Costa Rica 4
DO - Repubblica Dominicana 4
ET - Etiopia 4
HR - Croazia 4
JM - Giamaica 4
KZ - Kazakistan 4
ML - Mali 4
NG - Nigeria 4
NZ - Nuova Zelanda 4
SK - Slovacchia (Repubblica Slovacca) 4
A1 - Anonimo 3
BO - Bolivia 3
BY - Bielorussia 3
MD - Moldavia 3
MK - Macedonia 3
OM - Oman 3
RS - Serbia 3
SN - Senegal 3
XK - ???statistics.table.value.countryCode.XK??? 3
BA - Bosnia-Erzegovina 2
CM - Camerun 2
CY - Cipro 2
HU - Ungheria 2
Totale 19.403
Città #
Singapore 1.231
Chandler 910
Ashburn 605
Beijing 297
Dallas 277
New York 259
Dublin 247
Hefei 227
Rome 210
Jacksonville 192
San Mateo 190
Munich 180
Ann Arbor 167
Los Angeles 164
Jakarta 162
Nürnberg 157
Milan 132
Nanjing 131
Chicago 128
Cattolica 120
Marseille 114
Wilmington 109
The Dalles 107
Boston 98
Frankfurt am Main 96
Ho Chi Minh City 84
Izmir 80
Woodbridge 79
São Paulo 78
Moscow 75
Helsinki 73
Princeton 73
Hong Kong 70
Dearborn 68
Seattle 68
Kent 67
Bremen 64
Boardman 61
Seoul 58
Hanoi 53
Buffalo 52
Houston 50
Turku 50
Brussels 49
Warsaw 47
Nanchang 45
Tokyo 45
Brooklyn 41
Düsseldorf 41
Hangzhou 39
Redwood City 39
London 37
Fairfield 35
Nuremberg 34
Tianjin 34
Zhengzhou 34
Santa Clara 33
North Bergen 32
Toronto 30
Hebei 28
Lawrence 28
Rio de Janeiro 28
Kraków 27
Lancaster 26
Pune 26
Augusta 25
Denver 25
Norwalk 25
Stockholm 24
University Park 24
Hyderabad 23
Guangzhou 22
Leawood 22
Atlanta 21
Johannesburg 21
Mountain View 21
Chennai 20
Montreal 20
Portsmouth 20
Shenyang 20
Changsha 19
Fremont 19
Manchester 19
Poplar 19
Abidjan 18
Phoenix 18
Baghdad 17
Jiaxing 17
Lappeenranta 17
Vienna 17
Belo Horizonte 16
Ottawa 16
Kunming 15
Orem 15
Shanghai 15
Zurich 15
Amsterdam 14
Dhaka 14
Mumbai 14
Porto Alegre 14
Totale 9.152
Nome #
Post-COVID-19 global health strategies: the need for an interdisciplinary approach 496
From small nodule to overt HCC: a multistep process of carcinogenesis as seen during surveillance 321
Portal vein thrombosis: insight into physiopathology, diagnosis, and treatment 319
13C-methionine breath tests for mitochondrial liver function assessment. 244
The role of small intestinal bacterial overgrowth in Parkinson's disease 227
13C-breath tests in the study of microsomal liver function 222
Improvement of mortality rate and decrease in histologic hepatic injury after human cord blood stem cell infusion in a murine model of hepatotoxicity. 214
-High prevalence of celiac disease in patients with lactose intolerance 212
-Hepatic steatosis and vascular disease 211
Post-COVID-19 global health strategies: the need for an interdisciplinary approach 206
-Catholic university experience with molecular adsorbent recycling system in patients with severe liver failure 203
-Improvement of mortality rate and decrease in histologic hepatic injury after human cord blood stem cell infusion in a murine model of hepatotoxicity 201
A) Bacillus clausii therapy to reduce side-effects of anti-Helicobacter pylori treatment: randomized, double-blind, placebo controlled trial. 198
134C-breath tests in the study of mitochondrial liver function 198
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 194
-Moxifloxacin-based strategies for first-line treatment of Helicobacter pylori infection. 189
Gut microbiota compositional and functional fingerprint in patients with alcohol use disorder and alcohol-associated liver disease 188
Human cordonal stem cell intraperitoneal injection can represent a rescue therapy after an acute hepatic damage in immunocompetent rats. 176
Early prediction of response to sorafenib in patients with advanced hepatocellular carcinoma: the role of dynamic contrast enhanced ultrasound 176
Safety and efficacy profile of G-CSF therapy in patients with acute on chronic liver failure 175
Something more to say about calcium homeostasis: the role of vitamin K2 in vascular calcification and osteoporosis 175
13C-breath tests in the study of microsomial liver function 175
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 173
Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development 173
13C-methionine breath tests for mitochondrial liver function assessment 171
-No evidence of hematopoietic stem cell mobilization in patients submitted to hepatectomy or in patients with acute on chronic liver failure 166
TACE with degradable starch microspheres (DSM-TACE) as second-line treatment in HCC patients dismissing or ineligible for sorafenib 164
Early prediction of response to Sorafenib in patients with advanced hepatocellular carcinoma: the role of dynamic contrast enhanced ultrasound 163
Effect of rifaximin on gut microbiota composition in advanced liver disease and its complications 163
-How does human stem cell therapy influence gene expression after liver injury? Microarray evaluation on a rat model 161
-Human cordonal stem cell intraperitoneal injection can represent a rescue therapy after an acute hepatic damage in immunocompetent rats 161
. High prevalence of Cag-A positive H. pylori strains in ischemic stroke: a primary care multicenter study. 159
Levofloxacin-based triple therapy vs. quadruple therapy in second-line Helicobacter pylori treatment: a randomized trial. 158
CD133+ stem cell mobilization after partial hepatectomy depends on resection extent and underlying disease 157
Levofloxacin-based triple therapy in first-line treatment for Helicobacter pylori eradication 157
Treatment of H. pylori infection: a review. 155
Liver transplantation in patients with alcoholic liver disease: A retrospective study 154
Contrast-enhanced ultrasound in the short-term evaluation of hepatocellular carcinoma after locoregional treatment 153
Bacteroides thetaiotaomicron in the gut: molecular aspects of their interaction. 152
13C-breath tests in the study of mitochondrial liver function 150
-Bacillus clausii effect on gene expression pattern in small bowel mucosa using DNA microarray analysis 149
Diagnosis of bowel diseases: the role of imaging and ultrasonography 148
Beta-lactamase inhibitor enhances Helicobacter pylori eradication rate. 147
Delta13CO2 excretion and expression of dyspeptic symptoms in patients evaluated for Helicobacter pylori infection by [13C] urea breath test 147
-The decrease in cytokine concentration during albumin dialysis correlates with the prognosis of patients with acute on chronic liver failure 146
COVID-19 atypical Parsonage-Turner syndrome: a case report 143
Transdifferentiation of stem cells in pancreatic cells: state of the art 143
Transarterial chemoembolization with degradable starch microspheres (DSM-TACE): an alternative option for advanced HCC patients? Preliminary results 141
Something more to say about calcium homeostasis: the role of vitamin K2 in vascular calcification and osteoporosis 140
Levofloxacin based regimens for the eradication of Helicobacter pylori 138
-Improvement of mitochondrial function evaluated by ketoisocaproic acid breath test in patients with HCV infection undergoing albumin dialysis 138
Malnutrition in COVID-19 survivors: prevalence and risk factors 137
Prevention and treatment of hepatic encephalopathy: focusing on gut microbiota 137
Residual respiratory impairment after COVID-19 pneumonia 137
Portal vein tumor thrombosis revascularization during sorafenib treatment for hepatocellular carcinoma 136
-From stem cell to solid organ. Bone marrow, peripheral blood or umbilical cord blood as favorable source? 136
Regression of lactose malabsorption in coeliac patients after receiving a gluten-free diet. 135
High Prevalence and Gender-Related Differences of Gastrointestinal Manifestations in a Cohort of DM1 Patients: A Perspective, Cross-Sectional Study 135
. Quick test: a new test for the diagnosis of duodenal hypolactasia. 134
-Can 13C urea breath test predict resistance to therapy in Helicobacter pylori infection? 133
Reverse time-dependent effect of alphafetoprotein and disease control on survival of patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma 129
Clinical characteristics of metabolic associated fatty liver disease (MAFLD) in subjects with myotonic dystrophy type 1 (DM1) 129
Rescue therapy by portal infusion of autologous stem cells in a case of drug-induced hepatitis 128
Something more to say about calcium homeostasis: the role of vitamin K2 in vascular calcification and osteoporosis. 128
TACE with degradable starch microspheres (DSM-TACE) as second-line treatment in HCC patients dismissing or ineligible for sorafenib 128
Psychological Distress After Covid-19 Recovery: Reciprocal Effects With Temperament and Emotional Dysregulation. An Exploratory Study of Patients Over 60 Years of Age Assessed in a Post-acute Care Service 128
Correlation Between QElaXto Techniques and Supersonic Imagine for Liver Stiffness Quantification in Chronic Liver Disease 125
Liquid melevodopa versus standard levodopa in patients with Parkinson disease and small intestinal bacterial overgrowth 124
Different Antibiotic No Culture Eradicating (DANCE) strategy: An easy way to manage H. pylori eradication 122
How does human stem cell therapy influence gene expression after liver injury? Microarray evaluation on a rat model 119
Liver Stiffness in Pediatric Patients with Fatty Liver Disease: Diagnostic Accuracy and Reproducibility of Shear-Wave Elastography 118
Mono, dual and triple moxifloxacin-based therapies for Helicobacter pylori eradication 114
Rescue therapy by portal infusion of autologous stem cells in a case of drug-induced hepatitis. 112
Saccharomyces boulardii and Antibiotic-Associated Diarrhea: Effectiveness of Prophylactic Use 112
Dynamic Contrast-Enhanced Ultrasound in the Prediction of Advanced Hepatocellular Carcinoma Response to Systemic and Locoregional Therapies 111
A) Quantitative evaluation of liver function by the methionine and aminopyrine breath tests in the early stages of liver transplantation 111
Usefulness of contrast enhanced ultrasound in monitoring therapeutic response after hepatocellular carcinoma treatment 111
Liver Resection versus Radiofrequency Ablation plus Transcatheter Arterial Chemoembolization in Cirrhotic Patients with Solitary Large Hepatocellular Carcinoma 111
Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules 110
Dynamics of liver stiffness predicts complications in patients with HCV related cirrhosis treated with direct-acting antivirals 109
Hug sign in intraprocedural cone-beam-CT to predict short-term response to combined treatment of hepatocellular carcinoma 108
Subclinical atherosclerosis is linked to small intestinal bacterial overgrowth via vitamin K2-dependent mechanisms 108
Is there a role for anticoagulants in portal vein thrombosis management in cirrhotic patients? 107
Anticoagulants in cirrhotic patients: controversies and certainties in PVT management 106
What we should know about portal vein thrombosis in cirrhotic patients: A changing perspective 104
Contrast-enhanced ultrasound patterns of hepatocellular adenoma: an Italian multicenter experience 103
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in children with household exposure to adults with COVID-19: Preliminary findings 103
Probiotics and small bowel mucosa: Molecular aspects of their interactions 102
Functional and metabolic disorders in celiac disease: new implications for nutritional treatment 102
The role of elastography in non-Alcoholic fatty liver disease 102
Diagnostic and Prognostic Role of Extracellular Vesicles in Pancreatic Cancer: Current Evidence and Future Perspectives 101
Review article: breath testing for human liver function assessment. 101
Bariatric-metabolic surgery versus lifestyle intervention plus best medical care in non-alcoholic steatohepatitis (BRAVES): a multicentre, open-label, randomised trial 100
Personalized Therapy in a Multidisciplinary Team Improves Survival in Patient with HCC: The Hepatocatt Experience 96
Usefulness of contrast-enhanced ultrasound (CEUS) in Inflammatory Bowel Disease (IBD) 96
Madelung's disease and acute alcoholic hepatitis: case report and review of literature 96
Minimal Hepatic Encephalopathy is Associated with Increased Cerebral Vascular Resistance. A Transcranial Doppler Ultrasound Study 96
Fibrostenosing Crohn's Disease: Pathogenetic Mechanisms and New Therapeutic Horizons 93
The Gemelli Ultrasound Chronic Pancreatitis Score: A Non-invasive Tool for the Diagnosis of Chronic Pancreatitis 92
Multiparametric Dynamic Ultrasound Approach for Differential Diagnosis of Primary Liver Tumors 92
Totale 14.997
Categoria #
all - tutte 81.062
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 81.062


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021727 0 0 0 0 0 61 101 31 128 182 196 28
2021/20221.176 86 97 36 95 94 35 25 190 34 64 185 235
2022/20233.146 349 349 254 523 270 398 187 215 309 122 121 49
2023/20241.533 79 356 60 44 66 262 89 48 30 118 168 213
2024/20253.689 68 80 276 137 303 109 168 205 509 389 830 615
2025/20264.986 1.249 293 774 1.040 1.534 96 0 0 0 0 0 0
Totale 19.613